Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Inovio Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 9.12M 6.14M 9.8M 4.12M 13.47M
Cost of Goods Sold (COGS) incl. D&A - 2.11M - - -
COGS excluding D&A - 0 - - -
Depreciation & Amortization Expense 1.68M 2.11M 2.01M 1.99M 2.1M
Depreciation 237,222 194,629 142,197 173,750 328,752
Amortization of Intangibles 1.44M 1.91M 1.87M 1.82M 1.77M
Gross Income - 4.04M - - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 21.4M 23.26M 30.01M 26.77M 32.91M
Research & Development 9.41M 13.26M 20.03M 17.98M 21.37M
Other SG&A 11.99M 10M 9.98M 8.78M 11.54M
Other Operating Expense 0 0 0 0 0
Unusual Expense 249,279 (2.4M) (8.69M) (1.98M) 46.67M
EBIT after Unusual Expense (249,279) 2.4M 8.69M 1.98M (46.67M)
Non Operating Income/Expense (1.01M) 72,892 587,000 1.15M 1.96M
Non-Operating Interest Income 2,293 74,514 34,285 166,113 171,214
Equity in Affiliates (Pretax) (9.24M) (969,914) (2.39M) 1.63M 0
Interest Expense 0 0 0 0 0
Gross Interest Expense 0 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (24.46M) (17.64M) (15.3M) (19.71M) (66.08M)
Income Tax (917,000) 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (24.46M) (17.64M) (15.3M) (19.71M) (66.08M)
Minority Interest Expense (47,439) (24,950) (51,150) (44,025) (55,084)
Net Income (24.41M) (17.61M) (15.25M) (19.67M) (66.03M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (24.41M) (17.61M) (15.25M) (19.67M) (66.03M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (24.41M) (17.61M) (15.25M) (19.67M) (66.03M)
EPS (Basic) (1.32) (0.68) (0.48) (0.56) (1.44)
Basic Shares Outstanding 18.68M 25.8M 31.56M 34.13M 46.09M
EPS (Diluted) (1.32) (0.68) (0.48) (0.56) (1.44)
Diluted Shares Outstanding 18.68M 25.8M 31.56M 34.13M 46.09M
EBITDA (12.28M) (17.11M) (20.21M) (22.65M) (19.45M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.